SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Financial Collapse of 2001 Unwinding -- Ignore unavailable to you. Want to Upgrade?

To: Elroy Jetson who wrote (7333)2/24/2021 8:27:32 PM
From: Snowshoe  Read Replies (1) | Respond to of 13784
 
I'll be getting my second dose of the Pfizer vaccine next week.



To: Elroy Jetson who wrote (7333)2/26/2021 6:18:15 AM
From: Snowshoe  Read Replies (3) | Respond to of 13784
 
A third Pfizer dose? The Covid-19 vaccine maker is studying booster shots.
nbcnews.com

In an interview with NBC News' Lester Holt, Pfizer CEO Albert Bourla said the hope is that a third dose will boost the immune response even higher, offering better protection against variants.

"We believe that the third dose," Bourla said, "will raise the antibody response 10- to 20- fold."


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News